These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32766818)

  • 41. Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan.
    Aoki T; Fujinuma Y; Matsushima M
    BMJ Open; 2022 Jan; 12(1):e054348. PubMed ID: 34996796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.
    von Buedingen F; Hammer MS; Meid AD; Müller WE; Gerlach FM; Muth C
    BMC Fam Pract; 2018 Jul; 19(1):131. PubMed ID: 30055583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soft clustering using real-world data for the identification of multimorbidity patterns in an elderly population: cross-sectional study in a Mediterranean population.
    Violán C; Foguet-Boreu Q; Fernández-Bertolín S; Guisado-Clavero M; Cabrera-Bean M; Formiga F; Valderas JM; Roso-Llorach A
    BMJ Open; 2019 Aug; 9(8):e029594. PubMed ID: 31471439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifying multimorbidity clusters with the highest primary care use: 15 years of evidence from a multi-ethnic metropolitan population.
    Soley-Bori M; Bisquera A; Ashworth M; Wang Y; Durbaba S; Dodhia H; Fox-Rushby J
    Br J Gen Pract; 2022 Mar; 72(716):e190-e198. PubMed ID: 34782317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus.
    Muth C; Blom JW; Smith SM; Johnell K; Gonzalez-Gonzalez AI; Nguyen TS; Brueckle MS; Cesari M; Tinetti ME; Valderas JM
    J Intern Med; 2019 Mar; 285(3):272-288. PubMed ID: 30357955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimorbidity patterns and risk of frailty in older community-dwelling adults: a population-based cohort study.
    Tazzeo C; Rizzuto D; Calderón-Larrañaga A; Roso-Llorach A; Marengoni A; Welmer AK; Onder G; Trevisan C; Vetrano DL
    Age Ageing; 2021 Nov; 50(6):2183-2191. PubMed ID: 34228784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimorbidity and functional status in older people: a cluster analysis.
    Machón M; Mateo-Abad M; Clerencia-Sierra M; Güell C; Poblador-Pou B; Vrotsou K; Gimeno-Miguel A; Prados-Torres A; Vergara I
    Eur Geriatr Med; 2020 Apr; 11(2):321-332. PubMed ID: 32297200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study.
    Zhu Y; Edwards D; Mant J; Payne RA; Kiddle S
    BMC Med; 2020 Apr; 18(1):78. PubMed ID: 32272927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis.
    Guisado-Clavero M; Roso-Llorach A; López-Jimenez T; Pons-Vigués M; Foguet-Boreu Q; Muñoz MA; Violán C
    BMC Geriatr; 2018 Jan; 18(1):16. PubMed ID: 29338690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of multimorbidity in conditions of extreme poverty: a population-based study of older adults in rural Burkina Faso.
    Odland ML; Payne C; Witham MD; Siedner MJ; Bärnighausen T; Bountogo M; Coulibaly B; Geldsetzer P; Harling G; Manne-Goehler J; Ouermi L; Sie A; Davies JI
    BMJ Glob Health; 2020; 5(3):e002096. PubMed ID: 32337079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study.
    Rogero-Blanco E; Del-Cura-González I; Aza-Pascual-Salcedo M; García de Blas González F; Terrón-Rodas C; Chimeno-Sánchez S; García-Domingo E; López-Rodríguez JA;
    Eur J Gen Pract; 2021 Dec; 27(1):90-96. PubMed ID: 33982632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany.
    van den Bussche H; Koller D; Kolonko T; Hansen H; Wegscheider K; Glaeske G; von Leitner EC; Schäfer I; Schön G
    BMC Public Health; 2011 Feb; 11():101. PubMed ID: 21320345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
    Hasan Ibrahim AS; Barry HE; Hughes CM
    Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study.
    Heikkala E; Mikkola I; Jokelainen J; Timonen M; Hagnäs M
    BMC Health Serv Res; 2021 Sep; 21(1):964. PubMed ID: 34521389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polypharmacy patterns: unravelling systematic associations between prescribed medications.
    Calderón-Larrañaga A; Gimeno-Feliu LA; González-Rubio F; Poblador-Plou B; Lairla-San José M; Abad-Díez JM; Poncel-Falcó A; Prados-Torres A
    PLoS One; 2013; 8(12):e84967. PubMed ID: 24376858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy.
    Rieckert A; Trampisch US; Klaaßen-Mielke R; Drewelow E; Esmail A; Johansson T; Keller S; Kunnamo I; Löffler C; Mäkinen J; Piccoliori G; Vögele A; Sönnichsen A
    BMC Fam Pract; 2018 Jul; 19(1):113. PubMed ID: 30021528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. General practitioners' views on polypharmacy and its consequences for patient health care.
    Köberlein J; Gottschall M; Czarnecki K; Thomas A; Bergmann A; Voigt K
    BMC Fam Pract; 2013 Aug; 14():119. PubMed ID: 23947640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polypharmacy in multimorbid older adults: protocol for a systematic review.
    Sirois C; Laroche ML; Guénette L; Kröger E; Cooper D; Émond V
    Syst Rev; 2017 May; 6(1):104. PubMed ID: 28526062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.